Financial Architects, Inc Codexis, Inc. Transaction History

Financial Architects, Inc

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2019 Nov 06, 2019	SELL	$12.75 - $19.01 $138,643 - $206,714	-10,874 Closed	0 $0
Q1 2019 May 13, 2019	BUY	$15.53 - $22.15 $168,873 - $240,859	10,874 New	10,874 $223,000
Q1 2019 May 03, 2019	SELL	$15.53 - $22.15 $234,968 - $335,129	-15,130 Closed	0 $0
Q3 2018 Oct 29, 2018	BUY	$13.35 - $19.1 $53,760 - $76,915	4,027 Added 36.27%	15,130 $259,000
Q2 2018 Aug 03, 2018	BUY	$10.35 - $16.45 $26,775 - $42,556	2,587 Added 30.38%	11,103 $160,000
Q1 2018 Apr 23, 2018	BUY	$8.0 - $12.8 $68,128 - $109,004	8,516 New	8,516 $94,000

125

59.9M

25.9K

20.1K

Ticker CDXS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,494,100
Market Cap $284M
Description
Codexis, Inc. discovers, develops, and sells enzymes and other proteins. It offers biocatalyst products and services; intermediate chemicals products that are used for further chemical processing; and Codex biocatalyst panels and kits that enable customers to perform chemistry screening. The company also provides biocatalyst screening and protei...

Get notified when there are updates to the investment portfolio of Financial Architects, Inc, based on Form 13F filings with the SEC.

Stay updated on Financial Architects, Inc with notifications on news.